1. Home
  2. CELZ

as of 12-05-2025 4:00pm EST

$2.34
+$0.12
+5.41%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Chart Type:
Time Range:
Founded: 1998 Country:
United States
United States
Employees: N/A City: PHOENIX
Market Cap: 10.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 124.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.79 EPS Growth: N/A
52 Week Low/High: $1.69 - $6.90 Next Earning Date: 11-07-2025
Revenue: $6,000 Revenue Growth: -45.45%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered CELZ Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 64.19%
64.19%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Creative Medical Technology Holdings Inc. News

CELZ Breaking Stock News: Dive into CELZ Ticker-Specific Updates for Smart Investing

All CELZ News

Share on Social Networks: